Position in GSK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,048
-$55 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,010
of 1,032 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairman Group, LLC holds $485,757 across 8 Drug Manufacturers - General names. GSK ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
986 | $248,117 | |
| 2 | MRK |
Merck & Co., Inc.
|
669 | $85,966 | |
| 3 | PFE |
Pfizer Inc
|
3,288 | $79,175 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
718 | $41,371 | |
| 5 | JNJ |
Johnson & Johnson
|
104 | $26,412 | |
| 6 | NVO |
Novo Nordisk A S
|
63 | $3,020 | |
| 7 | GSK |
GSK plc
This page
|
20 | $1,048 | |
| 8 | BIIB |
Biogen Inc.
|
3 | $648 |
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,048 | 20 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,103 | 20 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $980 | 20 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $863 | 20 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $768 | 20 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $774 | 20 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,382 | 100 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,088 | 100 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,850 | 100 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,287 | 100 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,706 | 100 | Shares | Sole | 2024-03-26 | |
| No filing history on record for this holder in this stock. | ||||||